Isodiol International Inc ISOLF

RE:CTO reasoning plain and simple

[ConnectTheDot1]

On this link of BCSC https://www.bcsc.bc.ca/About_Issuers/Issuer_Information/?partyid=Y7Q4V6O5W7K3E7X7C6DCE7Q0 It showed that isol received financing: On 2017 /12/21 20$M at 1.25$ as first tranche But the deal announced on 2017/12/19 was 30$ M at 1.25$ Where was the second tranche of 10$M?????!!! https://m.canadianinsider.com/isodiol-international-inc-announces-strategic-30-000-000-cad-financing Then we got the last financing 10M$ at 0.73$ And the Anson fund joined another 8$M for total of 18$M received in May 25th... So what happened for the second tranche of 10$@1.25$? Can someone explain ? Thanks

CBDANDME wrote: All documents are on BCSC website for all to read and all to see that that is
nothing short more detail needed by the BCSE 

2. The reporting issuer’s continuous disclosure is deficient because:
2a. Financial statements of the reporting issuer, or the auditors’ report accompanying the financial statements, do not comply with the requirements of NI 51-102 Continuous Disclosure Obligations (NI 51-102), National Instrument 81-106 Investment Fund Continuous Disclosure (NI 81-106) or National Instrument 52-107 Acceptable Accounting Principals, Auditing Standards and Reporting Currency.
2c. The reporting issuer’s AIF, MD&A, MRFP, information circular, or business acquisition reports do not contain information for each of the content items required by NI 51-102 or NI 81-106.
 
 
 
https://www.bcsc.bc.ca/About_Issuers/Issuer_Information/?partyid=Y7Q4V6O5W7K3E7X7C6DCE7Q0